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Abstract
Background
Emerging adulthood is often-overlooked in current gastrointestinal (GI) health research;
however, epidemiological evidence suggests that GI disorders are increasing in this population.
The Rome IV criteria have taken a biopsychosocial approach to better understand the etiology of
functional gastrointestinal disorders (FGID). Therefore, exploring biopsychosocial factors
associated with GI functioning in emerging adults is warranted. The purpose of this study was to
first define common GI symptom subgroups within emerging adults and then to characterize
these group differences with key biopsychosocial factors encompassing diet, depression and
anxiety symptoms, as well as physical and social functioning related to quality of life.
Methods
A total of 956 emerging adults from a southeastern US university were recruited.
Participants completed a comprehensive survey on GI symptoms, psychosocial factors and
demographics. Scores derived from the National Institutes of Health (NIH) Patient-Reported
Outcomes Measurement Information System (PROMIS®) GI symptoms scales were used for
latent class analyses. The most parsimonious number of classes were identified using Bayesian
Information Criterion. A multivariate analysis of variance (MANOVA) was conducted
comparing the differences in latent classes to key biopsychosocial factors.
Results
Latent class analysis uncovered three statistically significant GI symptom patterns within
the sample identified by the degree of severity: Normal (649 individuals, 64.15% of the sample),
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Mild (257 individuals, 30.30% of the sample), and Moderate (50 individuals, 5.55% of the
sample). Chi-square analysis indicated that the groups differed in biological sex. Next, results
from the MANOVA indicated that the 3 latent classes were significantly different on most of the
biopsychosocial factors, F(8, 1896) = 25.909, p < .001, Pillai’s V = .155, partial η2 = .077.
Conclusions
The majority of this study’s sample had low scores on the various PROMIS GI measures
and thus were considered to have healthy GI functioning. However, a surprisingly large
proportion of the sample reported mild and moderate GI symptom severity. Latent classes
identified 3 groups: Normal (n=649), Mild (n=257), and Moderate (n=50). These groups were
different based on symptom levels but also biopsychosocial factors. Notably, the anxiety and
depression levels increased with GI symptom levels. In fact, the Moderate group met clinical
cutoffs on several measures. This study demonstrated that significant impairment in GI
functioning emerges at much earlier ages that is commonly assumed. In addition, these GI
symptom levels were associated with important biopsychosocial factors. Assessing GI
functioning in emerging adults may provide important insights into understanding the
development of FGIDs.
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Introduction
There are few studies assessing the prevalence of functional gastrointestinal disorders
(FGIDs) in the general population. According to the data available, between 10% and 25% of the
general US population meet the diagnostic criteria for an FGID (Agréus, Svärdsudd, Nyrén, &
Tibblin, 1995; Drossman et al., 1993; Jones & Lydeard, 1992; Wilson, Roberts, Roalfe, Bridge,
& Singh, 2004). Thirty percent of individuals experiencing a GI symptom will seek primary
medical care (Drossman et al., 1993; Hungin, Chang, Locke, Dennis, & Barghout, 2005) and of
those patients, 80% will be diagnosed with a FGID (Hungin et al., 2005). As of 2017, over 40%
of patients consulting a gastroenterology specialist do so in reference to functional
gastrointestinal disorders (Lacy & Patel, 2017).
Generally, emerging adults (age 18-25) are viewed as a physically healthy cohort
(Institute of Medicine and National Research Council, 2015) and consequently often-overlooked
in current gastrointestinal (GI) health research. Newer epidemiological studies suggest that
FGIDs are increasing in emerging adults (Harris, 2010; Kappelman, 2013; Trivedi & Keefer,
2015; Urlep, Blagus, & Orel, 2015). As many as 65% of emerging adults are experiencing
symptoms (Lee, Mun, Lee, & Cho, 2011) and approximately one third are seeking medical care
(Jafri, Yakoob, Jafri, Islam, & Ali, 2005).
Emerging adulthood marks the shift from being dependent on a care provider to taking
independent responsibility for seeking medical care (Institute of Medicine and National Research
Council, 2013). Research indicate this population have decreased adherence to medication and
attend fewer physician appointments (Harris, Gordon-Larsen, Chantala, & Udry, 2006; Trivedi

1

& Keefer, 2015). Furthermore, this period establishes fundamental health and self-care behaviors
that carry forward into adulthood (Auerbach, Admon, & Pizzagalli, 2014; Dalton & Hammen,
2018; Harris, 2010). Adverse health behaviors have been observed in the amount of sleep,
cigarette use, drinking, exercise, and eating habits of emerging adults (Dalton & Hammen, 2018;
Harris et al., 2006; Olson, Hummer, & Harris, 2017).
The current understanding of FGIDs is supported with evidence that multidimensional
interactions between biological, psychological, and social/environmental distress are involved in
the onset and severity of FGIDs (Drossman, 2016; Engel, 1977). These associations have led to
the adoption of a biopsychosocial model in the study of FGIDs (Drossman, 2016). Interestingly,
a culmination of biopsychosocial changes occurs in the emerging adult population (Arnett, 2000;
Trivedi & Keefer, 2015). However, detailed observations of GI and biopsychosocial functioning
in emerging adults have not yet been investigated.
The purpose of this study was to first define homogenous GI symptom subgroups within
emerging adults and then to characterize their differences using key biopsychosocial factors
encompassing diet, mood and anxiety disorders, and health related quality of life.

2

Background
The following literature highlights current theories and research on functional
gastrointestinal disorders, diet and psychosocial factors within the emerging adult population.
Functional Gastrointestinal Disorders: A Brief Overview
History of FGIDs.
The study of GI disorders was heavily impacted by the 17th century Cartesian beliefs that
the mind and body are separate. Mind-body dualism deemphasized the importance of
psychological variables to the etiology of many illnesses such as FGID. Those experiencing
psychological distress about physical symptoms without any apparent morphological signs were
quickly dismissed as exaggerating or psychosomatic. It wasn’t until the early 19th century when
observations of emotions affecting gastric function were documented (Drossman, 2016). By the
mid 20th century, several scientific studies had uncovered a direct relationship between emotions
and changes in bowel function (Alvarez, 1949; Drossman, 1998; Drossman, 2016). Nevertheless,
the 1960s re-emphasized the presence of biological markers in classifying GI illnesses and
psychosocial factors were again discounted. This approach resulted in many gastrointestinal
symptoms such as IBS to be classified as a “psychosomatic” disorder (Drossman, 2016).
The emergence of the biopsychosocial model in the study of FGIDs. It wasn’t until the
late 1970’s that a unified theory of biological and psychological interactions was offered: The
biopsychosocial model (Engel, 1977). The biopsychosocial model defines illness as the
combined “…product of biological, psychological, and social subsystems interacting at multiple
levels” (Drossman, 2016, p. 1265). This approach leads researchers to not only measure

3

biological markers, but to also include variables such as health-related quality of life, patient
perceptions and behaviors, symptom severity and daily function. Another transformation in
understanding GI disorders occurred through the development of the field of
neurogastroenterology in the 1990s (Drossman, 2016). Neurogastroenterology employed the
latest technology to provide scientific evidence of the physiological interactions between the gut
and brain, setting the foundation for the gut-brain axis model (Drossman, 2016). The gut-brain
axis can be described as the system of “bidirectional communication between the central and the
enteric nervous system, linking emotional and cognitive centers of the brain with peripheral
intestinal functions” (Carabotti, Scirocco, Maselli, & Severi, 2015, p. 203).
The 21st century marked a paradigm shift in defining the gut-brain axis with the emphasis
on the role of the gut microbiota as a key physiological element in the development of FGIDs.
Gut microbiota are the populations of microorganisms present in the body’s gastrointestinal tract
(Evrensel & Ceylan, 2015, p. 239) and “engage in bidirectional communication with the brain
via neural, endocrine, and immune pathways” (Van Oudenhove et al., 2016, p. 1362). These
microorganisms have been associated with both the presentation of IBS symptoms and
psychological disorders including anxiety and depression (Cryan, & Dinan, 2012; Van
Oudenhove et al., 2016). The extent of these interactions has resulted in the emergence of the
term microbiome-gut-brain axis (Van Oudenhove et al., 2016) thus expanding the conceptual
framework of the gut-brain axis. Just as the field of gastroenterology expanded and evolved, so
did the criteria for classifying and diagnosing GI disorders.
Development of the diagnostic manual for FGIDs. The first major unified effort to
produce a GI classification and diagnostic manual began in the late 1980s with the publication of
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the Rome I criteria in 1994. The Rome I was the first comprehensive book aimed at identifying
and describing GI disorders lacking in any visible organic abnormalities, such as IBS. In sync to
the scientific community’s interpretation of GI disorders, the publishing of the Rome II criteria
in 2000 officially coined the term neurogastroenterology, formalizing the field of gut-brain
research (Kellow et al., 1999; Wood, Alpers, & Andrews, 1999). The Rome III criteria,
published in 2006, utilized more evidence-based data to support GI classifications. The most
recent version published in 2016, the Rome IV criteria, has undertaken the task of further
redefining FGIDs based on the latest scientific discoveries along with providing the latest
diagnostic and classification criteria (Schmulson & Drossman, 2017). According to the latest
definition:
FGIDs are disorders of gut–brain interaction. It is a group of disorders classified by GI
symptoms related to any combination of the following: motility disturbance, visceral
hypersensitivity, altered mucosal and immune function, altered gut microbiota, and
altered central nervous system processing. (Drossman, 2016, p. 1268)
In addition to changing the definition of FGIDs, the Rome IV criteria also added the
microbiome, food, and nutrition as important elements in the study of GI function (Barbara et al.,
2016). Additionally, genetics and culture have been added to the current list of significant factors
(age, gender, and women’s health) that impact GI disorders. Another key change in the Rome IV
criteria was to officially adopt the biopsychosocial model, thus anchoring the new definition of
FGIDs as disorders of gut-brain interaction. The biopsychosocial model emphasizes the
interaction between all these diverse elements and their potential role in explaining the
heterogeneity of GI disorders.
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The six FGID domains.
The Rome IV criteria contains 6 primary FGID domains for adults encompassing over 33
types of FGIDs and two domains dedicated to children. Each FGID is classified based on the
patient’s report of symptom type and severity. A symptom is “…a noticeable experiential change
in the body or its parts that is reported by the patient as being different from normal and may or
may not be interpreted as meaningful” (Drossman, 2016, p. 1266). Functional GI disorders
consider clusters of symptoms experienced together to describe a syndrome. A syndrome
“…relates to the association of several clinically recognizable symptoms or signs that occur
together to define a clinical entity” (Drossman, 2016, p. 1266). Therefore, FGIDs can be
conceptualized as a “…syndrome based on symptoms that cluster together and are diagnosed by
Rome criteria” (Drossman, 2016, p. 1266). Historically, individuals seek out medical support
when they experience GI symptoms. Additionally, it is these symptoms that patients use to
describe their illness to their clinician. Therefore, although FGIDs can include morphological
changes or motility abnormalities, they are not the primary criteria used to classify an FGID
(Drossman, 2016; Schmulson & Drossman, 2017).
Notably new to the Rome IV criteria, FGIDs may be thought of as a “spectrum of chronic
GI disorders with combinations of symptoms … existing on a continuum rather than as discrete
disorders” (Simren, Palsson, & Whitehead, 2017, p. 4). Multiple studies support this new
description by the Rome IV criteria providing scientific evidence that patients can transition
from one disorder to another and can receive multiple diagnoses (Chey et al., 2015; Lacy et al.,
2016; Shah et al., 2018; Whitehead et al., 2002). However, the primary symptoms experienced is
used to classify the six domains of FGIDs.
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Table 1 FGID Domains According to the Rome IV Criteria.
FGID Domains

Primary Symptoms

1.

Esophageal Disorders

Heartburn, chest pain, or reflex

2.

Gastroduodenal Disorders

Dyspepsia, belching, nausea/vomiting

3.

Bowel Disorders

Constipation, diarrhea, and gas/bloating

4.

Centrally Mediated Disorders of GI Pain

Abdominal pain

5.

Gallbladder and Sphincter of Oddi Disorders

Sudden pain usually experienced during gallstone or gallbladder attacks

6.

Anorectal Disorders

Fecal incontinence and anorectal pain

Note. (Drossman, 2016).

One of the most studied FGID domains is Bowel Disorders which can be grouped into 6
main categories. Additionally, four subcategories were created within the IBS category, the most
frequently diagnosed GI disorder (Chey, Kurlander, & Eswaran, 2015) covering 11.2% of the
world’s population (Lacy et al., 2016).
Table 2 Bowel Disorder Categories.
Bowel Disorders
1.

Irritable Bowel Syndrome (IBS)
a.

IBS-C: Predominant in constipation

b.

IBS-D: Predominant in diarrhea

c.

IBS-M: Mixed bowel habits

d.

IBS-U: Unclassified

2.

Functional Constipation

3.

Functional Diarrhea

4.

Functional Abdominal Bloating/Distention

5.

Unspecified Functional Bowel Disorders

6.

Opioid-induced Constipation

Note. Simren, Palsson, & Whitehead, 2017

Almario et al. evaluated FGID symptom prevalence within the general US adult
population (n=71,812, ages 18-65) using the National Institutes of Health (NIH) PatientReported Outcomes Measurement Information System (PROMIS®) GI scales (Almario et al.,
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2018). Eight overarching FGID symptom domains (abdominal pain, bloating/gas, bowel
incontinence, constipation, diarrhea, swallowing, reflux, and nausea/vomiting) were assessed
including the occurrence of overlapping symptoms. Over 61% of their study sample endorsed at
least one symptom within the past 7 days. Of those, 58.4% indicated they experienced two or
more symptoms concurrently. Based on their findings, close to 1/3 of their sample population
experienced reflux/heartburn, making it the most prevalent symptom. One quarter reported
abdominal pain and a fifth of the participants experienced bloating, diarrhea, and constipation.
This study included emerging adults in their population sample, finding that over 54% (n=6,954)
reported the occurrence of at least 1 FGID symptom within the past week. However, further
descriptions of FGID symptoms within emerging adults were not provided.
The most commonly studied FGID syndrome in emerging adults is IBS. According to the
ACHA-National College Health Assessment II national survey for the Fall 2017 semester, 3.2%
of the undergraduate students surveyed (n=5,789) had been diagnosed by a healthcare
professional of having IBS (American College Health Association, 2017, pg. 3). Another study
focused on recurrent abdominal pain (RAP) and IBS prevalence in emerging adults. The study
concluded that those individuals who had higher levels of RAP also experienced higher rates of
recurrence five years later for RAP and IBS, resulting in higher levels of functional disability,
school absence, and clinic visits for abdominal stress (Walker, Guite, Duke, Barnard, & Greene,
1998). A third study evaluated the frequency of IBS in college students demonstrating that 34%
of the sample (n=508, mean age: 22+/-2.8yrs) experienced clinical symptoms (Jafri et al., 2005).
This previous research demonstrated clinical rates of IBS in the emerging adult population but is
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limited in that it does not capture a broader range of general GI distress or subclinical
symptomatology.
GI symptoms are usually present before an FGID diagnosis is made and therefore serve
as a likely reason for seeking medical care (Almario et al., 2018; Spiegel et al., 2014). However,
fewer than 20% of the US population who experience GI symptoms will actually seek medical
care (Sandler, Stewart, Liberman, Ricci, & Zorich, 2000). It therefore stands to reason that
measuring GI symptoms within a healthy, non-clinical population rather than relying on
clinically diagnosed cases may provide additional insight into the overall prevalence of GI
distress. Additionally, FGIDs including IBS are considered heterogenous, not only in their
diagnostic classification but also in their potential pathogenesis (Adam, Liebregts, & Holtman,
2007; Jones, Van Oudenhove, & Talley, 2012). With that in mind, applying the biopsychosocial
model to determine what factors are potentially responsible for FGIDs is needed.
The Biopsychosocial Model of FGIDs
Exploring the etiology of FGIDs expanded with the biopsychosocial model, providing
researchers with a new conceptual framework that incorporated research from both psychosocial
and biological fields. Specifically, the biopsychosocial model placed equal value in researching
the patient’s reported experience of illness with the physical indicators of disease (Drossman &
Dumitrascu, 2006), resulting in studies of a singular mind-body system. Consequently,
researchers identified a bi-directional communication pathway between the mind and GI tract,
termed the gut-brain axis (Drossman, 2016; Van Oudenhove et al., 2016). The gut-brain axis
provided evidence that changes in either the mind or gut can disrupt the balance of the other.
More specifically, biopsychosocial factors impacting the gut-brain axis could be traced to the
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risk of developing GI symptoms, symptom severity, and affecting treatment outcomes
(Drossman, 2016; Van Oudenhove et al., 2016).
A closer look at the biopsychosocial factors involved in FGIDs reveal a diverse range of
domains. At present, these include but are not limited to environmental, cultural, and
psychosocial factors, including the composition of an individual’s gut microbiome, diet, and
nutrition (Van Oudenhove et al., 2016).
Figure 1 The Biopsychosocial Model

Psychosocial
Factors
Life Stress
Mental State
Social Support

Environmental
Factors
Trauma
Chronic Stress
Parental Behaviors

FGID

Gut-Brain Axis

Symptoms
& Severity

Outcome
Quality of Life
Daily Function

Physiological
Factors
Inflammation
Altered Gut Microbiota
Food/Diet
Adapted from Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV.
Gastroenterology. 150, 1262-1279 by D.A. Drossman, 2016.

Environmental factors: childhood, trauma, & chronic stress.
Environmental factors are important contributors to the lifespan development of an
individual. The degree of susceptibility to FGIDs can be traced to early childhood development,
where children learn to modify their behaviors in response to their parent’s reaction to their
illness (Levy et al., 2004). Exposure to any form of abuse, whether psychological, physical, or
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sexual, will increase the likelihood of experiencing an FGID (Bradford et al., 2012), specifically
affecting symptom severity and clinical outcomes (Drossman, 2011). Furthermore, experiencing
a major loss can influence the onset of an FGID (Bitton et al., 2008; Lackner & Gurtman, 2004;
Sperber, Drossman, & Quigley, 2012). However, an environment with chronic and high levels of
life stress has proven to be one of the strongest factors for developing FGIDs (Drossman et al.,
2000). Emerging adults are especially susceptible to chronic stress as they transition into
adulthood (Cohen, Burt, & Bjorck, 1987; D’Zurilla & Sheedy, 1991). Stress provoking
environments for emerging adults include attending college and adjusting to new social settings
(Ross, Niebling, & Heckert, 1999). Consequently, the inability to properly cope with chronic
stress frequently result in depression and maladaptive eating behaviors in emerging adults
(Dalton & Hammen, 2018; McGonagle & Kessler, 1990).
Environmental factors affecting FGIDs can occur at any point in life, ranging from early
childhood conditioning, experiencing acute adverse events, to sustaining ongoing periods of
stress. Environmental factors illustrate the multidimensional aspect of the biopsychosocial model
because they not only influence the susceptibility to FGIDs, they can also foster psychological
disorders.
Psychosocial factors: mood disorders, anxiety disorders & quality of life.
In addition to demonstrating the multidimensional aspect of FGIDs, the biopsychosocial
model also accounts for the bi-directional communication pathways between domains, such as
the gut-brain axis. The gut-brain axis is a defining representation of the relationship between
psychosocial factors and FGIDs. Psychosocial disturbances can ignite the exacerbation of GI
symptoms or they can be a consequence of experiencing GI symptoms (Van Oudenhove et al.,
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2016). Additionally, psychosocial factors have great influence over whether someone will seek
medical care and also over the effectiveness of treatment (Drossman, 2016). According to the
latest Rome IV overview, psychosocial factors associated with the gut-brain axis that interact
with the development and severity of FGIDs include mood disorders (depression and suicide
ideation), anxiety disorders, somatization, and cognitive-affective processes (Van Oudenhove et
al., 2016).
Based on a systematic review, when patients’ GI symptoms are categorized into mild,
moderate, or severe levels discrete associations with levels of care and psychosocial variables
emerge (Drossman et al., 2011; Drossman, 2016). For example, 40% of patients who endorse
mild GI symptoms are commonly treated in primary care settings and psychological disorders
are not elevated and the general quality of life is good (Drossman, 2016). In comparison,
approximately 30%-35% of patients will meet the criteria for moderate GI symptoms. This
segment will experience a stronger association between their social environment, psychological
distress and abdominal pain, creating some interference in daily activity. Finally, individuals
with severe GI symptom levels make up 20%-25% of patients and are more frequently seen by a
gastroenterologist. Individuals experiencing severe GI symptoms also experience high levels of
anxiety, depression, and/or personality disorders. Additionally, history of abuse, major loss, and
poor social networks are strongly associated with this group. Furthermore, these individuals
experience frequent disruptions in their daily activity due to their GI symptoms (Drossman,
2016). These findings need to be replicated in general non-patient populations.
Anxiety disorders are closely associated with the onset and duration of FGIDs. Studies
have found that anxiety disorders are directly associated with the biological stress response
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processes, and as a result, can alter pain tolerance and motility (Van Oudenhove et al., 2016). In
a sample of 604 college students (age= 20.93 ± 1.47 years), 36.9% endorsed IBS symptoms,
according to Rome III criteria, with 13.9% presenting with both IBS and GAD (Afridi, Ahmad,
Sethi, & Irfan, 2017). Additionally, it’s been argued that anxiety disorders have a greater impact
on the risk, comorbidity, and outcome of IBS than depression (Roy-Byrne et al., 2008).
Mood disorders are associated with depression and suicide ideation (Van Oudenhove et
al., 2016). The prevalence of depression was found in 30% of medical-seeking patients
presenting with FGIDs (Addolorato et al., 2008) with 15% to 38% of clinical patients with IBS
presenting with suicidal ideation (Miller, Hopkins, & Whorwell, 2004), while anxiety disorders
were revealed in 30%-50% of clinical patients with FGIDs (Oudenhove, Levy et al., 2016).
However, depression alone, can alter the number of GI symptoms an individual experience
including the number of diagnoses made (Bouchoucha et al., 2013; Van Oudenhove et al., 2011).
Only a few studies have evaluated GI symptoms and depression in an emerging adult population.
One study with emerging adults found that 13.6% (n=773) of their sample reported moderate to
major depression (Lisznyai, Vida, Nemeth, & Benczur, 2014).
The comorbidity of depression and anxiety can be associated with poor health outcomes
and inferior quality of life (Lackner et al., 2010; Lackner & Gurtman, 2005). Furthermore,
experiencing chronic GI symptoms can also result in psychological consequences on overall
health-related quality of life (HQoL)., i.e. “…one’s general well-being, daily function status, and
sense of control over the symptoms.” (Drossman, 2016, p. 1273). Studies have shown that HQoL
was significantly lower in individuals with IBS than healthy individuals (Badia et al., 2002).
Studies concerned with health outcomes in emerging adults were very limited. Nevertheless, one
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study evaluating HQoL including a population group of 16 to 23-year old participants concluded
that males reported higher scores than females (Jörngården, Wettergen, & Vo Essen, 2006).
Albeit promising, research is currently limited on general emerging adult population
samples. The prevalence of depression is found to be higher in emerging adults than other age
groups, with 5.8% meeting symptom criteria (Weitzman, 2004). Yet, the presence of depressive
symptoms in emerging adults, regardless of meeting a clinical diagnostic level, have shown to
have an effect on health behaviors, including diet (Dalton & Hammen, 2018).
Biological factors: microbiome, food, & dietary habits.
The 21st century brought new scientific exploration of the gut microbiota’s enigmatic
relationship with gut function and brain behavior (Ghoshal & Srivastava, 2014). Gut microbiota
are the intestinal microbes located within the GI tract that feed on the undigested components of
foods consumed (Barbara et al., 2016). The gut microbiota ecosystem (microbiome) is an everpresent part of the bidirectional interaction between the gut-brain axis (Osadchiy, Martin, &
Mayer, 2019) suggesting a microbiome-gut-brain axis (Oudenhove, et al, 2016). Present research
has demonstrated the role gut microbiota has in “energy homeostasis, immune function, and the
development of certain diseases” (Dong & Gupta, 2019, p. 231). Environmental factors including
stages of early life development, drugs, stress, and diet influence the balance and composition of
the gut microbiome (Barbara et al., 2016; Evrensel & Ceylan, 2015). Adverse input from these
factors result in a dysfunctional gut microbiota ecosystem, termed dysbiosis (Sundin, Öhman,
Simrén, & Magnus, 2017). Researchers studying dysbiosis, frequently encounter the presence of
anxiety, depression, and IBS, thus concluding that a strong interaction exist between dysbiosis
and these factors (O’Mahony et al., 2005).
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Research on the relationship between gut microbiota and FGID have employ advanced
technological and analytic methods, yet much is still unclear as to the extent of this relationship.
A recent study employing new machine learning techniques, found that microbial diversity
decreased as IBS symptom severity increased, distinguishing between mild/moderate, and severe
levels compared to healthy sample groups, and that these differences were not mediated by diet
or medications (Tap et al., 2017).
The gut microbiome is fundamentally established early in life and can remain fairly
stable even with interference from drugs, infections, and diet, however, studies have shown that
to some degree, diet can modify both microbiota composition and function in adults (Osadchiy et
al., 2019, p. 327). Consequently, researchers have begun exploring diet as a potential means to
create changes in physiological and psychological symptoms via the gut microbiome (Barbara et
al., 2016; Chey, 2013; Evrensel & Ceylon, 2015). Studies of dietary measurements have
provided evidence of associations with FGIDs, dysbiosis of the gut microbiome, and
psychological disorders (Evrensel & Ceylon, 2015; Francisconi et al., 2016). Importantly, the
relationship between GI symptoms and eating behaviors and diet has been marked as significant
(Ananthakrishnan et al., 2015; Drossman, 2016; Gibson, Varney, Malakar, & Muir, 2015; Lee et
al., 2015).
Assessing dietary intake can be evaluated at the nutrient, food group, and eating pattern
levels (Jacobs & Steffen, 2003; Lee et al., 2015). Nutrients such as vitamins and minerals, fats,
fibers, carbohydrates, and proteins, characterize diet at the most basic level (Hu, 2002). At a
higher level of analysis are food groups. Food groups are defined as grains, vegetables, fruits,
diary, and protein, as marked by the food pyramid (Marcoe, Juan, Yamini, Carlson, & Britten,
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2006). At the most macro level of analysis are dietary patterns, such as the Mediterranean or
Western diet. Dietary patterns are defined as “the quantities, proportions, variety or combination
of different foods, drinks, and nutrients in diets, and the frequency with which they are habitually
consumed” (2015 Dietary Guidelines Advisory Committee, 2015, p. 8). “Dietary factors that
reportedly trigger symptoms include eating patterns as well as specific foods and/or food
components” (Barbara et al., 2016, p. 1306).
The Western dietary pattern, also known as the American diet is “characterized by high
fat, high sugar, high level of red and processed meat, high levels of refined grains and a lower
level of fiber” (Dong & Gupta, 2019, p. 234). Individuals on the Western diet are at moderate
risk for developing IBS (Buscail et al., 2017), have low gut microbiota diversity, show higher
levels of inflammation, and have an increased risk of obesity, colon cancer, and type 2 diabetes
(Dong & Gupta, 2019; Miyoshi et al., 2017; Schulfer et al., 2018; Turnbaugh et al., 2009). The
Mediterranean diet, considered the healthiest diet, is “characterized by a beneficial fatty acid
profile; higher intake of fiber, vegetables, and fruits; and with lower intake of sugar and red
meat” (Dong & Gupta, 2019, p. 234). Individuals on a Mediterranean diet have rich microbial
diversity, decreased levels of inflammation and are at lower risk of cardiovascular disease and
obesity (Ley et al., 2005; Miyoshi et al., 2017; Rivera et al., 2007).
Evaluating eating habits in an emerging adult population showed that 89% of emerging
adults were not meeting healthy dietary recommendations, missing serving level requirements
for all standard food groups (Song, Schuette, Huang, & Hoerr, 1996). The amount of
carbohydrates consumed exceeded 33% to 46% and they were 53% to 58% of their daily
vegetable serving requirements (2015-2020 Dietary Guidelines for Americans - Ch2, p42, 2015).
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Current research on diet and FGIDs indicated mixed results. A study found patients
diagnosed with FGIDs were more inclined to snack throughout the day, eating fewer meals per
week than their non-FGID counterparts (Barbara et al., 2016). A large population study
(n=44,350) in France found the Western dietary pattern connected to a moderate risk for IBS
(Buscail et al., 2017). Higher levels of constipation were found in Japanese college students who
frequently skipped breakfast (Fujiwara, 2012) and another study demonstrated the risk of
ulcerative colitis increased with a high consumption of soft drinks (Nie & Zhao, 2017). Further
exploring common associations between an individual’s diet and gastrointestinal functioning
may offer insight into the extent diet plays in the development of FGIDs.
Conceptual Framework: Defining Patterns of FGID Symptoms in Emerging Adults
Emerging adulthood is often-overlooked in current GI health research (Park, Mulye,
Adams, Brindis, & Irwin, 2006). However, as a critical period of development it is important to
determine the active biopsychosocial factors associated with various GI functioning in emerging
adults. The purpose of this study was to define common GI symptom subgroups within emerging
adults and characterize their differences based on key biopsychosocial factors. To accomplish
this task, the National Institutes of Health (NIH) Patient-Reported Outcomes Measurement
Information System (PROMIS®) GI symptom scales was administered (Spiegel et al., 2014). The
PROMIS-GI is currently the only PRO that has been validated to measure symptoms of multiple
FGID domains in both a general and clinical population group. The use of the NIH PROMIS-GI
scales afforded this study with a means to measure a broad range of GI functioning and symptom
levels within a general emerging adult population group. To date, there is no comprehensive
study exploring general GI functioning in the emerging adult population using the PROMIS-GI
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symptom scales. To identify underlying GI symptom patterns, a latent class analysis approach
was employed. Latent class analysis (LCA) is a statistical method that allows the researcher to
use a set of observed variables to identify hidden but meaningful patterns resulting in a number
of homogenous subgroups of participants (latent classes) (Schreiber, 2016). The key
biopsychosocial factors measured included dietary patterns, eating behaviors, mood and anxiety
disorders, and physical and social functioning related to quality of life. Between class differences
were established by these variables using a MANOVA. Currently, this is the only study that
sought to identify underlying GI patterns and associated psychosocial factors within a general
emerging adult population group.
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Method
Participants
Undergraduates enrolled in introductory psychology courses at a large university in the
south-eastern United States were recruited to participate in this study for course credit.
Introductory psychology is a required course for all programs at this university. Eligibility
criteria excluded vulnerable populations and required participants to be between the age of 18
and 25 years and able to complete an online questionnaire in the English language. All measures
were administered online. This study was approved by the Institutional Review Board.
Measures
The online survey included 198 questions assessing the following: FGID symptoms,
dietary patterns, eating behaviors, depression and anxiety symptoms and emotional and physical
functioning. In addition, the survey included demographic items such as age, gender,
race/ethnicity, education, income, and living arrangements. The survey took approximately 30
minutes to complete. Nine validity check questions were also included in the questionnaire as a
determining variable for respondent data retention or elimination. The data analysis for this paper
was generated using Qualtrics software (Qualtrics, Provo, UT).
Functional gastrointestinal assessment.
The NIH PROMIS-GI symptom scales. The National Institutes of Health (NIH) PatientReported Outcomes Measurement Information System (PROMIS®) Gastrointestinal Symptom
Scales (PROMIS-GI) were developed in 2014. The PROMIS-GI scales are disease-agnostic, thus
allowing for the characterization of a broad range of GI symptoms within the general population
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(Shah, Almario, Speigel, & Chey, 2018; Spiegel et al., 2014). These scales have been employed
in several GI studies validating its ability to measure GI symptom burden and to characterize GI
symptom differences (Shah et al., 2018). Importantly, the PROMIS-GI symptom scales may be
effective in identifying clinical thresholds for action (Spiegel et al., 2014). The PROMIS-GI
scales were developed using multiple patient focus groups and an extensive systematic literary
review. A psychometric evaluation confirmed the internal construct validity of the PROMIS-GI
Scales (Spiegel et al., 2014). The PROMIS-GI has been validated in studies as an effective PRO
measure to be used in both clinical and general populations (Spiegel et al., 2014). The PROMISGI scales evaluate eight GI symptom domains, of which this study focused on six: abdominal
pain (6 items), gas/bloating (12 items), diarrhea (5 items), constipation (9 items),
gastroesophageal reflux (GER) (13 items), and nausea/vomiting (4 items). Individuals’ scores
were provided as a T-score metric with 50 representing the U.S. general population mean with a
standard deviation (s.d.) of 10 (Spiegel, et al, 2014). The higher the T-score, the greater the
severity of the symptom. Scores were calculated by pre-determined algorithms available via the
PROMIS website. T-scores were then converted into GI symptom severity levels using the
suggested general PROMIS T-Score threshold range of mild (t-scores between 55 and 60),
moderate (t-scores between 60 and 70), and severe (t-scores above 80).
Dietary assessments.
14-Item Mediterranean Diet Adherence Screener (MEDAS). The dietary behaviors
were evaluated in this study due to their confirmed validity in association with FGIDs
(Ananthakrishnan, 2015; Barbara et al., 2016; Chey, 2013; Drossman, 2016; Evrensel & Ceylon,
2015; Francisconi et al., 2016; Gibson, et al., 2015; Lee, 2015). Assessing dietary patterns is one
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of the preferred methods used in research (Hu, 2002) as they describe eating behaviors generally
consistent over time (Quatromoni et al., 2002). The Mediterranean Diet (MedDiet) is a
frequently recommended dietary pattern by nutritional research and the USDA (Scientific Report
of the 2015 Dietary Guidelines Advisory Committee, Part D. Chapter 2). This study employed
the validated 14-Item (MEDAS) to assess individuals’ degree of adherence to the MedDiet. The
14-Item MEDAS is the English version of the original Spanish version, PREvencion con
DIetaMEDiterranea (PREDIMED) (Papadaki et al., 2018). It is scored (0-14) based on 14
questions (Martínez-González et al., 2012). This questionnaire has been validated in Spain and
the UK for its objective assessment of adherence to the MedDiet (Martínez-González et al.,
2012; Papadaki et al., 2018). The main outcome measure was the level of adherence to the
Mediterranean diet.
Psychosocial assessments.
Past research has confirmed that anxiety, depression and HQoL is associated with many
FGID symptoms and their level of severity (Addolorato et al., 2008; Badia et al., 2002; Lisznyai
et al., 2014; Miller et al., 2004; Oudenhove et al., 2016; Roy-Byrne et al., 2008). Specifically,
relevant to evaluating FGIDs, the Rome IV committee provided within their supplementary
materials their recommended measures for assessing psychosocial factors associated with FGIDs
(Oudenhove et al., 2016). These include the GAD-7, PHQ-9 and SF-36.
Generalized Anxiety Disorder Screener (GAD-7). This study evaluated generalized
anxiety disorder (GAD) using the Generalized Anxiety Disorder Screener (GAD-7) instrument,
which recorded the level of general anxiety experienced within the past two weeks using a set of
7 questions (Spitzer, Kroenke, Williams, & Lowe, 2006). The GAD-7 scored each question from
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0 (not at all) to 3 (nearly every day) with a total score of 21. Summary scores of 5, 10, and 15
were used as threshold values for mild, moderate and severe anxiety (Spitzer et al., 2006). The
GAD-7 was constructed using existing GAD criteria from the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV) (Spitzer et al., 2006). It has been validated by
multiple studies (Löwe et al., 2008).
Patient Health Questionnaire (PHQ-9). The Rome IV committee recommends screening
for suicide ideation when depression is severe and accompanied with feelings of hopelessness
and severe/persistent abdominal pain (Oudenhove et al., 2016). To evaluate depressive
symptoms, the Patient Health Questionnaire (PHQ-9) was administered. In keeping to the
diagnostic criteria of the DMS-IV, the PHQ-9 measures the level of depression, including suicide
ideation (Kroenke, Spitzer, & Williams, 2001). This instrument consists of 9 items, scored 0 (not
at all) to 3 (nearly every day), with a total summary score of 27. The severity of depression can
be calculated using validated cut-off points with scores above 10 qualifying as a form of
depression, and scores of 15 or greater indicating major depression (Kroenke et al., 2001). The
PHQ-9 is a simplified version of the 3-page Patient Health Questionnaire used by clinicians to
diagnose their patients for depression. The PHQ-9 has been validated and replicated by mental
health professionals conducting patient interviews and comparing the PHQ-9 with current
measurement tools in place (Kroenke et al., 2001).
RAND 36-Item Health Survey 1.0 (SF-36). Studies have concluded that GI symptoms
correlate negatively with HQoL (Halder et al., 2003). This study employed the RAND 36-Item
Health Survey 1.0 (SF-36) measuring eight separate domains along with two summary scores on
mental and physical health (Hays, Sherbourne, & Hazel, 1993). A mental summary score was
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calculated using the four domains: emotional wellbeing, social functioning, energy/fatigue, and
role limitations due to emotional problems. The physical health summary score was derived from
the remaining four domains: physical functioning, pain, role limitations based on physical health,
and general health perception (Cunningham, Nakozono, Tsai, & Hays, 2003). Of note, the
version of the SF-36 used in this study was based on the RAND-36 scoring algorithms rather
than the original SF-36 scoring method. The key difference is that the RAND-36 summary
scores were calculated based on the assumption that physical and mental health is correlated
(Cunningham et al., 2003). The original SF-36 was constructed in 1992 during the Medical
Outcome Study from longer patient-completed forms (Ware & Sherbourne, 1992). The RAND36 uses the exact same items as the SF-36 (Cunningham et al., 2003). It has been validated in
numerous studies for accurately measuring health-related quality of life (Oudenhove et al.,
2016).
Demographic assessments.
Demographic information collected in this study can be grouped by: (i) general standard
items (age, gender, race/ethnicity, marital status); (ii) socioeconomic (ii) birth profile (birth
mode, breastfed); (iii) current housing; (iv) and physiological profile (BMI, allergies, taking
antibiotics, probiotics, or multivitamins). See Table A1 for detailed list of question items.
Statistical Analysis
Data from the PROMIS-GI symptoms scales were analyzed in LatGold v5.1.0.18311
(Statistical Innovations Inc.), a latent class analysis software package. LCA methods have the
same goal as traditional cluster analysis, in that both attempt to create the largest between-cluster
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and smallest within-cluster differences. However, unlike standard cluster methods, LCA uses a
probabilistic model-based approach rather than distance measures of dissimilarity (Kent, Jensen,
& Kongstad, 2014). Additional advantages for using the LCA includes: (i) greater control of the
criteria used to determine clusters, (ii) normal distribution of variables are not required, and (iii)
mixed measurement levels can exist between variables in the same test (Schreiber, 2016;
Vermunt & Magidson, 2002). The ideal model was based on appropriate model fit, the number
of individuals per class, the certainty of being assigned to one class (membership probability),
and significant difference between classes (Kongsted & Nielsen, 2017).
Class differences based on biopsychosocial factors were then explored using multivariate
analysis of variance (MANOVA) analysis. Subgroups that differed significantly were compared
at a pair level using the least significant difference (LSD) test. A p value of < 0.05 was
considered statistically significant. Both MANOVA and LSD tests were conducted in SPSS
(IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM
Corp.).
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Results
The final study sample totaled 956 emerging adults between the age range of 18 and 25
(M=18.97, SD = 1.47) with 58.3% identifying as female, and 57.3% identified as Caucasian. To
evaluate the presence of GI symptoms within the emerging adult sample group, the T-scores
derived from the PROMIS-GI symptoms scales were assigned a rating of 1 through 4, as
illustrated in Figure 2, marking symptom severity.
Figure 2 PROMIS Symptom Severity Range
50

60

70

80

(1)

(2)

(3)

(4)

Normal Limits

Mild

Moderate

Severe

Note. Symptom severity ratings were based on the recommended PROMIS T-Score ranges, using the mean of 50 and standard
deviation (SD) of 10. Normal limits (1) = t-scores < 55; Mild (2) = t-scores between 55 – 60; Moderate (3) = t-scores between
60 – 70; Severe (4) = t-scores > 70. Adapted from http://www.healthmeasures.net/score-and-interpret/interpret-scores/promis

Symptom prevalence was assessed using the severity scores. As presented in Table 3,
25.8% of the emerging adult sample group did present at least one GI symptom.
Table 3 Overall GI Symptom Severity Found in Participants (n=956)
GI Symptom Severity

Belly Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Within Normal Limits (1)

750 (78.5%)

845 (88.4%)

870 (91%)

608 (63.6%)

699 (73.1%)

891 (93.2%)

Mild (2)

99 (10.4%)

77 (8.1%)

53 (5.5%)

247 (25.8%)

142 (14.9%)

49 (5.1%)

Moderate (3)

91 (9.5%)

34 (3.6%)

32 (3.3%)

99 (10.4%)

105 (11%)

15 (1.6%)

Severe (4)

16 (1.7%)

1 (0.1%)

2 (0.2%)

10 (1%)

1 (0.1%)

-

Note. Levels of severity were interpreted using the threshold range guidelines developed by the NIH to be used with their
PROMIS measures. Within Normal Limits = T-scores < 55; Mild = T-Scores between 55 and 60; Moderate = T-Scores between
60 and 70; Severe = T-scores > 70. There was no endorsement for severe constipation within the sample group.

Having confirmed the presence of GI symptoms in this emerging adult sample group,
latent class analysis (LCA) was explored using the assigned symptom severity scores 1-4.
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A baseline model was created using a 1-Class (latent) cluster model (Myrseth &
Notelaers, 2018). Classes were subsequently added and compared to the baseline 1-Class model.
Model sizes with up to 7 classes were calculated as there were no previous studies that suggested
the number of classes for conducting a latent class analysis using the PROMIS-GI scales. Each
estimation model was replicated 10 times to determine the most frequently occurring Bayesian
Information Criterion results per model (Nielsen, Vach, Kent, & Kongsted, 2016). By selecting
the most common solution, the evaluations will be using the most likely scenario.
Model Selection
Table 4 provides an overview of the various information criteria considered in
determining the best model fit. The information criteria consisted of the likelihood ratio chisquared statistic (L2) and Bayes Information Criterion (BIC) with lower values indicating
improved model prediction of the data (Vermunt & Magidson, 2016, p.69). The L2 statistic
calculates the similarity between model-based estimated frequencies and observed frequencies
with smaller values indicating better model fit. The BIC accounts for model complexity and
endorses model parsimony of the latent classes, and when using sample sizes larger than 500,
proves to be a superior indicator to model fit compared to all other information criteria (Nylund,
Asparouhov, & Muthen, 2007, p. 563). A more formal assessment of the model holding true for
the population is determined by the p-value with p < 0.05 indicating a poor model fit. Due to
some of the GI symptom severity levels containing small group sizes, a bootstrapping method
was used to better assess the global fit of the model (Nylund et al., 2007). Additionally, entropy
R-squared was evaluated for quality of membership classification with values closest to 1
indicating improved probability of an individual belonging to just one class (Schreiber, 2016).
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Individual class sizes below 3% were considered to be too small for this study. Accordingly, the
class sizes in the 4-Class model and higher did not meet the minimum distribution requirement
and was thus eliminated. Of note, the 3-Class model indicated a small sample group (n=50) for
their 3rd class which would be acceptable if the cluster/class was describing an element that is
uncommon in the sampled emerging adults.
The 2-Class model had the lowest BIC, however, both the L2 and p-value were not ideal.
Additionally, according to the conditional bootstrap analysis, the 3-Class model showed a
statistically significant improvement over the 2-Class model (p < 0.05, 0.00 s.e.) for overall
model fit, thus the 3-Class model was selected.
Table 4 Summary of Statistical Model Fit Statistics Used for Model Selection
Model
BIC
L2
df
pa
Entropy
Class. Err.
Baseline 1-Class Model
6798.2738
1185.6210
940
1.00
1.00
0.0000
2-Class Model
6339.2847
603.0833
922
0.0020
0.7033
0.0621
3-Class Model
6344.9257
485.1760
904
0.0980
0.6426
0.1101
4-Class Model
6426.8327
443.5345
886
0.0640
0.6548
0.1139
5-Class Model
6518.9844
412.1377
868
0.0119
0.6022
0.1637
6-Class Model
6624.2116
393.8164
850
0.0142
0.6939
0.1347
7-Class Model
6722.1687
368.2251
832
0.0103
0.7045
0.1332
Note. Comparison between the 2-Class and 3-Class are shown with values in bold indicating optimal values. The 4-Class and
higher models did not meet the minimum group size criteria. BI = Bayesian information criterion; L2 = Likelihood-ratio; df =
degrees of freedom; p = p-value; Entropy = quality of predicting model classification with values closer to 1 preferred; Class.
Err. = classification errors.
a
p value calculated using bootstrap method.

Describing the Latent Classes
Between-class differences were described based on the high conditional probabilities
(values > 0.5) for class assignment, available in Table A2. Additionally, differences between
classes are graphically illustrated in Figure 2 based on the T-Score means for each class. The
differences between these classes are statistically significant (p < .001) for each symptom
domain, as shown in Table A3. It was concluded that the 3-Class model adequately identified
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three unique latent classes that were informative to the study and could be defined based on their
GI symptom patterns. The three classes were described as Normal (649 individuals, 64.15%),
Mild (257 individuals, 30.30%), and Moderate (50 individuals, 5.55%). Symptom severity
marked the main difference between these classes. The differences between the Mild, and
Moderate groups was found in the increased symptom severity of belly pain, gas/bloating, and
nausea/vomiting with the Moderate class also endorsing moderate constipation along with mild
diarrhea and reflux/heartburn. A comparison of the demographic information among the three
latent classes are provided in Table A5.
Figure 3 3-Class Model Profile Plot Using Conditional Mean T-Scores per Class

65

Mean T-Scores

60
55
50
45
40
Belly Pain

Normal

Constipation

Diarrhea

Mild (BP, GB, NV)

Gas / Bloating

Nausea /
Vomiting

Reflux /
Heartburn

Moderate (BP, GB, NV) + C / Mild (D, RE)

Note. PROMIS T-Score ranges for GI symptoms include Normal limits = < 55; Mild = between 55 – 60; Moderate = between
60 – 70; Severe = > 70.

Comparisons of Biopsychosocial Factors
Based on previous literature, this study hypothesized that the three latent classes will
differ on biopsychosocial factors with a decrease in psychosocial functioning as levels of GI
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symptoms increase (Mild and Moderate classes). Demographic analyses revealed differences
between the three groups in the proportion of men and women (χ2(2) = 75.431, p < .001) with
females dominating both the Mild and Moderate groups (Normal = 48.8%, Mild = 77.1%,
Moderate = 84%). Therefore, it was also hypothesized that the scores for biopsychosocial factors
for each of the GI groups would depend on sex. A two-way MANOVA was run with two
independent variables – sex and GI symptom groups – and five dependent variables Mediterranean diet (MEDAS) score, anxiety (GAD-7) score, depression (PHQ-9) score, and the
overall emotional (SF-36 MH) and physical functioning (SF-36 PF) scores. The combined
dependent variables were used to assess biopsychosocial functioning.
Evidence of multicollinearity was found, as assessed by Pearson correlation (|r| > 0.9)
between the SF-36 MH and PHQ-9, therefore, the mental health summary score for the SF-36
was removed. Univariate outliers were present in the data (n=25), as assessed by inspection of a
boxplot, and multivariate outliers (n=25), as assessed by Mahalanobis distance (p < .001).
Outliers were retained because analysis with and without these cases proved to have a
statistically trivial effect. The interaction effect between sex and GI symptom groups on the
combined dependent variables was statistically significant, F(8, 1896) = 2.638, p = .007, Pillai’s
V = .022, partial η2 = .011. Follow up univariate two-way ANOVAs were run for each dependent
variable.
Analysis showed a statistically significant interaction effect between sex and GI group for
physical functioning scores, F(2, 950) = 8.301, p < .001, partial η2 = .017, but not for the
Mediterranean diet score, F(2, 950) = 10.677, p = .069, partial η2 = .006, depression, F(2, 950) =
1.561, p = .210, partial η2 = .003, or anxiety, F(2, 950) = 1.388, p = .250, partial η2 = .003. As
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such, a simple main effects analysis for physical functioning was conducted. A statistical
difference was observed between GI groups and males for physical functioning, F(2, 950) =
36.837, p < .001, partial η2 = .072, and for females, F(2, 950) = 27.026, p < .001, partial η2 =
.054. Table A6 shows simple comparisons for differences in mean physical functioning scores
between GI groups for males and females demonstrating a statistically significant difference
between all three GI groups for both males and females. Thus, it could be concluded that GI
symptom groups and physical functioning scores vary by sex. However, the main interaction
effect between GI groups and sex was considered trivial due to the small effect size (partial η2 =
.011), warranting a separate evaluation of the main effects for GI groups and sex on
biopsychosocial factors.
There was a statistically significant main effect of GI symptom groups on the combined
dependent variables, F(8, 1896) = 23.322, p < .001, Pillai’s V = .179, partial η2 = .090. Follow
up univariate two-way ANOVAs were run, showing a statistically significant main effect of GI
groups on physical functioning, F(2, 950) = 61.194, p < .001, partial η2 = .114, depression, F(2,
950) = 47.924, p < .001, partial η2 = .092, anxiety, F(2, 950) = 54.438, p < .001, partial η2 =
.103, but not for the Mediterranean diet, F(2, 950) = 1.922, p =.147, partial η2 = .004.
Additionally, there was a statistically significant main effect of sex on the combined dependent
variables, F(4, 947) = 5.95, p < .001, Pillai’s V = .025, partial η2 = .025. Follow up univariate
two-way ANOVAs were run showing a statistically significant main effect of sex for the
Mediterranean diet, F(1, 950) = 16.794, p < .001, partial η2 = .017, and physical functioning,
F(1, 950) = 6.707, p = .010, partial η2 = .007, but not for anxiety, F(1, 950) = .873, p = .350,
partial η2 = .001, or depression, F(1, 950) = .017, p = .897, partial η2 = < .001.
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As such, a post hoc Tukey pairwise comparison was conducted to evaluate the
differences in mean biopsychosocial scores between GI symptom groups and also between sex.
Table 6 summarizes the comparison for GI symptom groups and Table 7 the sex differences.
Table 6 Differences Between Biopsychosocial Factors and GI Symptom Classes
Latent classification GI group
Mean (SD) or N [%]
Variables
Biological
Med diet1
Psychosocial
GAD-7
SF-36 (PF)
PHQ-9

MANOVA
main effect

Post hoc tests
Mean difference significance

F

p

η2

Normal
(v)
Mild

Normal
(v)
Moderate

Mild
(v)
Moderate

5.50
(1.84)

1.922

.147

.004

**

ns

ns

10.60
(6.45)
68.91
(18.37)
10.30
(6.525)

54.438

< 0.001

.103

***

***

***

61.194

< 0.001

.092

***

***

***

47.924

< 0.001

.092

***

***

*

Normal
(n=648)

Mild
(n=258)

Moderate
(n=50)

5.36
(2.05)

5.80
(1.93)

3.95
(4.43)
85.24
(10.85)
4.90
(4.57)

7.57
(5.58)
78.12
(13.69)
8.47
(5.63)

Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant difference.
ns = non-significant. The mean difference was significant at the .05 level. GAD-7= Generalized Anxiety Disorder; SF-36 (PF)
Social functioning summary score for physical functioning; PHQ-9 = Patient health questionnaire to evaluate depression;
1
Mediterranean dietary adherence score;
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001.

Table 7 Differences Between Biopsychosocial Factors and Sex
Male
Variables
Med diet
Normal GI
Mild GI
Moderate GI
GAD-7
Normal GI
Mild GI
Moderate GI
SF-36 (PF)
Normal GI
Mild GI
Moderate GI
PHQ-9
Normal GI
Mild GI
Moderate GI

MANOVA main effect for sex
on Biopsychosocial Factors

Female

Post hoc tests
Mean difference
significance

N

Mean (SD)

N

Mean (SD)

F

p

η2

Male (v) Female

332
59
8

5.13 (2.07)
5.12 (2.00)
3.75 (1.39)

316
199
42

5.59 (2.01)
6.00 (1.87)
5.83 (1.84)

8.779
8.886
7.397

.003
.003
.007

.009
.009
.008

**
**
**

332
59
8

3.07 (3.68)
6.56 (5.23)
11.63 (5.66)

316
199
42

4.88 (4.93)
7.86 (5.65)
10.40 (6.63)

22.815
3.332
.430

.000
.068
.512

.023
.003
.000

***
ns
ns

332
59
8

86.62 (9.44)
77.8 (13.62)
55.85 (22.24)

316
199
42

83.78 (12.00)
78.22 (13.75)
71.4 (16.72)

8.996
.056
11.185

.003
.813
.001

.009
.000
.012

**
ns
**

332
59
8

4.23 (4.13)
8.10 (4.79)
11.63 (5.48)

316
199
42

5.60 (4.90)
8.58 (5.87)
10.05 (6.74)

12.248
.427
.678

.000
.514
.411

.013
.000
.001

***
ns
ns

Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant
difference. ns = non-significant. The mean difference was significant at the .05 level. GAD-7= Generalized Anxiety
Disorder; SF-36 (PF) Social functioning summary score for physical functioning; PHQ-9 = Patient health questionnaire to
evaluate depression;
1
Mediterranean dietary adherence score;
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001.
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Discussion
Research on GI health has generally focused on adults who seek out medical treatment
for their GI symptoms. Indeed, the recent literature has demonstrated that GI symptoms are
common in the general population, however, there is very limited information on GI symptoms
and associated factors in emerging adults, those between the ages of 18 and 25. Identifying
patterns of GI symptoms in emerging adults along with associated biopsychosocial factors may
provide valuable information about the etiology of FGIDs and suggest the most effective
treatment strategies for these symptoms. Therefore, this study assessed both GI symptoms and
key biopsychosocial variables in a group of 956 emerging adults to determine if meaningful
patterns would emerge. Furthermore, this is the first study to evaluate a range of GI symptoms
within an emerging adult population using PROMIS-GI measures. Latent class analyses revealed
that 30% of the emerging adults surveyed experienced one or more GI symptom, with 5.5% of
the sample reaching levels of GI symptom severity associated with clinical diagnoses. Three
latent GI classes were identified, Normal (n=649, 64.15%), Mild (n=257, 30.30%), and Moderate
(n=49, 5.55%). GI symptom severity marked the main difference between these classes.
Additionally, differences were observed between men and women. The Mild and Moderate
groups were predominantly female.
Previous general U.S. population studies have indicated that between 35% and 69% of
the general population presents with at least one GI symptom (Almario et al., 2018; Camilleri et
al., 2005; Drossman et al, 1993). That rate is higher than the 30% that was obtained here in a
sample of emerging adults. Breaking down the data into specific GI symptom domains also
reveals differences across studies. For example, lower levels of heartburn/reflux and higher

32

levels of gas/bloating were obtained in the current study as compared to the National GI Survey
in 2015 (Almario et al., 2018).
Studies on GI symptoms in emerging adults are limited, however one indicated 51.2% of
Canadian-based university students endorsed at least one GI symptom (Norton et al., 1999) and
in another 65% of Korean-based nursing students reported more than one GI symptom (Lee et
al., 2011). The high incidence of GI symptoms in emerging adults given that this age range
should be of optimal health is surprising. One commonality between these studies is that all used
convenience samples of emerging adults that were college or professional students. Student
populations are under high stress (D’Zurilla & Sheedy, 1991) and these findings may reflect a
relationship between GI functioning and stress among the other factors described above.
A review of the literature indicates that GI symptoms are frequently associated with
anxiety and depression (Addolorato et al., 2008; Badia et al., 2002; Lisznyai et al., 2014; Miller
et al., 2004; Van Oudenhove et al., 2016; Roy-Byrne et al., 2008). For example, previous studies
showed 13.9% of their sample presenting with both IBS and anxiety (Afridi et al., 2017) and
another found depression in 30% of medical-seeking patients presenting with FGIDs
(Addolorato et al., 2008). In the current study, the Moderate GI symptom group met the GAD-7
threshold for moderate anxiety levels and the Moderate GI symptom group also met the PHQ-9
threshold score of 10 or higher for moderate or severe depression.
The gut-brain axis is the proposed communication pathway for psychosocial and GI
functioning to interact. The GI symptoms and associated psychosocial measures found in this
study are consistent with the existence of a gut-brain axis communication pathway. The bidirectional communication between the gut and brain is integral in maintaining homeostasis and
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an imbalance in either can have adverse consequences (Foster, Rinaman, & Cryan, 2017).
Following this theory, psychosocial functioning can excite or suppress the GI system, or GI
functioning can excite or suppress psychosocial functioning (Van Oudenhove et al., 2016). This
study observed that mood, anxiety, and GI symptom severity were strongly correlated and
therefore clearly interacting.
Diet was examined in relation to GI symptom groups and the results were not in the
direction that was expected. Generally psychosocial functioning was predicted to decrease as GI
symptom severity increased and diet was considered one aspect of psychosocial functioning.
Results suggest that the Mild GI symptom group actually exhibited higher levels of adherence to
the Mediterranean diet than either the Normal GI symptom group or the Moderate GI symptom
group. This finding may reveal an early response by individuals to eat a healthy diet in response
to GI symptoms. Alternatively, the particular diet examined here; the Mediterranean Diet is high
in legumes and vegetables. This diet may lead to higher levels of gas and bloating and may result
in mild GI symptoms.
Additionally, evidence of the regulation of the gut-brain axis via microbiota was
discussed, including how diet may influence this relationship. Although diet did present as a
differentiating factor between the three subgroups, it was not associated with GI health and its
effect was very small. It could be suggested that adherence to a healthy diet at this stage in life
may be limited in keeping the gut-brain axis in balance. The composition of the microbiota is
fundamentally established during childhood (Foster et al., 2017) and therefore, diets intended to
alter the microbiota may need to be more targeted and aggressive to achieve meaningful results.
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Limitations. The emerging adult population used here was drawn from a university
sample, thus generalizing results to the population of emerging adults remains to be determined.
However, it should be noted that the sample drawn were from a general psychology class,
required by all students, regardless of their major. This study was a cross-sectional study and
thus causation could not be determined. When GI and psychosocial symptoms emerged in
relation to one another could not be determined. Two PROMIS-GI scales were excluded from
the survey measures; one focused on disrupted swallowing and the other on bowel incontinence.
Furthermore, evidence suggest that GI symptom severity increase during menstruation
(Bernstein et al., 2014), however, this study did not account for this possible interaction between
menses and belly pain.
Future directions. This study demonstrated that over a third of emerging adults
attending college are experiencing at least one GI symptom and that these symptoms form
unique patterns, distinguishable by levels of severity in GI symptoms. Anxiety and depression
varied by severity of GI symptoms. Including all PROMIS-GI measures in future research would
provide a broader scope of GI functioning. Furthermore, additional insight will be gained by
comparing the GI symptom groups on other demographic and psychosocial measures. Future
studies should consider measuring GI and psychosocial variables over repeated intervals with a
time-series design. That way possible cause and effect relationships may be determined. Future
research evaluating GI symptoms in emerging adults should include healthcare seeking measures
to determine the likelihood that this population accesses medical support. Based on this study’s
findings, it is recommended that university health service providers evaluate patterns of GI
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health when students present with anxiety and depression, and conversely they should assess
anxiety and depression when students present with GI complaints.
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Appendix
Abbreviations

Definitions

CVD
FGID
GER
GI
HQoL
IBS
LCA
NIH
PRO
PROMIS
RAP
MedDiet
PREDIMED
MEDAS
STC

Cardiovascular disease
Functional Gastrointestinal Disorder
Gastroesophageal Reflux
Gastrointestinal
Health-related quality of life
Irritable Bowel Syndrome
Latent Class Analysis
National Institute of Health
Patient-Reported Outcome
Patient-Reported Outcomes Measurement Information System
Recurrent abdominal pain
Mediterranean Diet
PREvencion con DIetaMEDiterranea
Mediterranean Diet Adherence Screener
Starting the Conversation
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A1 Descriptive Characteristics of Participants
Variable
Age
18
19
20
21
22
23
24
25
Sex
Male
Female
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Puerto Rican
Mexican-American
Other Hispanic
Asians
American Indian
Other
Identified with 2+ ethnicities
Living Arrangements
On campus
Off campus
Total Household Income
0-50,000
50,001-100,000
100,001-150,000
≥ 150,001
Health
Allergies
Currently taking antibiotics
Taking antibiotics past 2 months
Taking probiotics
Taking multivitamins
Currently a smoker
Body Mass Index (BMI)
Underweight ≤ 18.5
Normal weight = 18.5 – 24.9
Overweight = 25 – 29.9
Obesity = BMI of 30 or greater
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n

%

515
222
94
52
33
19
10
11

53.9%
23.2%
9.8%
5.4%
3.5%
2.0%
1.0%
1.2%

399
557

41.7%
58.3%

548
114
51
14
108
92
10
19
81

57.3%
11.9%
5.3%
1.5%
11.3%
9.6%
1.0%
2.0%
8.5%

474
482

49.6%
50.4%

362
295
166
133

37.9%
30.9%
17.4%
13.9%

300
48
197
89
356
130

31.4%
5.0%
20.6%
9.3%
37.2%
13.6%

47
629
168
112

7.9%
65.8%
17.6%
11.7%

A2 Class Membership Probabilities of the 3-Class Model
Distribution of the three GI latent classes
PROMIS-GI Symptom Indicators
Belly Pain
Within Normal Limits
Mild
Moderate
Severe
Constipation
Within Normal Limits
Mild
Moderate
Severe
Diarrhea
Within Normal Limits
Mild
Moderate
Severe
Gas / Bloating
Within Normal Limits
Mild
Moderate
Severe
Nausea / Vomiting
Within Normal Limits
Mild
Moderate
Severe
Reflux / Heartburn
Within Normal Limits
Mild
Moderate
Severe

Normal
64.15%

Mild
30.30%

Moderate
5.55%

0.7992
0.1213
0.0149
0.0349

0.1864
0.8392
0.6836
0.2848

0.0144
0.0394
0.3015
0.6802

0.7013
0.1874
0.1852

0.2897
0.5434
0.0874

0.0090
0.2691
0.7274

0.6994
0.0717
0.0321
0

0.2726
0.7942
0.3254
0

0.0280
0.1342
0.6425
1.0000

0.8377
0.3973
0.0587
0

0.1543
0.5677
0.5626
0

0.0081
0.0350
0.3788
1.0000

0.7843
0.2777
0.2249
0.1953

0.2050
0.6172
0.5381
0.2248

0.0107
0.1051
0.2370
0.5799

0.6793
0.1347
0.0968
0

0.2888
0.6011
0.1918
0

0.0319
0.2642
0.7114
1.0000

Note. Items in bold indicate high conditional probabilities that characterize each class. Percent values represent the class size
based on the overall sample population.
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A3 Paired Comparisons Between Classes Within the 3-Class Model
Models for Indicators

p-value

Belly Pain

Models for Indicators

p-value

Constipation

Class

1

2

5.1e-6

Class

1

2

0.00017

Class

1

3

0.00040

Class

1

3

5.8e-14

Class

2

3

3.5e-5

Class

2

3

3.5e-6

Class

1

2

0.0031

Class

1

2

6.8e-15

Class

1

3

7.9e-5

Class

1

3

1.1e-7

Class

2

3

6.3e-6

Class

2

3

2.6e-6

Diarrhea

Gas / Bloating

Nausea / Vomiting

Reflux / Heartburn

Class

1

2

7.4e-15

Class

1

2

0.0011

Class

1

3

1.5e-14

Class

1

3

2.6e-10

Class

2

3

0.00011

Class

2

3

0.00053

Note. P-values reveal that all latent classes are statistically significantly different between the groups for GI symptoms.

40

A5 Descriptive Statistics of the Classes within the 3-Class model
Age (years)
Mean
Gender
Male
Female
Race/ethnicity
Non-Hispanic whites
Non-Hispanic blacks
Latinos
Asians
Other
Identified with 2+ ethnicities
Foreign born persons
Living Arrangements
On campus
Off campus
Total Household Income
0-50,000
50,001-100,000
100,001-150,000
≥ 150,001
Health
Allergies
Currently taking antibiotics
Taking probiotics
Taking multivitamins
Currently a smoker
Body Mass Index (BMI)
Underweight ≤ 18.5
Normal weight = 18.5 – 24.9
Overweight = 25 – 29.9
Obesity = BMI of 30 or greater

Normal1
(n=647)

Mild2
(n=257)

Moderate3
(n=49)

18.94 (SD = 1.437)

19.03 (SD = 1.536)

19.08 (SD = 1.592)

332 (51.2%)
316 (48.8%)

59 (22.9%)
199 (77.1%)

8 (16%)
42 (84%)

360 (55.6%)
96 (14.8%)
111 (17.1%)
63 (9.7%)
18 (2.8%)

157 (60.9%)
13 (5%)
53 (20.5%)
27 (10.5%)
8 (3.1%)

31 (62%)
5 (10%)
14 (28%)
2 (4%)
3 (6%)

330 (50.93%)
318 (49.07%)

121 (46.90%)
137 (53.10%)

23 (46%)
27 (54%)

245 (37.8%)
200 (30.86%)
119 (18.36%)
84 (12.96%)

100 (38.76%)
110 (42.64%)
39 (15.12%)
39 (15.12%)

17 (34%)
15 (30%)
8 (16%)
10 (20%)

185 (28.5%)
25 (3.9%)
52 (8%)
227 (35%)
81 (12.5%)

92 (35.7%)
16 (6.2%)
28 (10.9%)
102 (39.5%)
41 (15.9%)

20 (40%)
7 (14%)
9 (18%)
27 (54%)
8 (16%)

52 (8.02%)
424 (65.43%)
115 (17.75%)
57 (8.8%)

20 (7.75%)
171 (66.28%)
35 (13.57%)
23 (8.91%)

4 (8%)
34 (68%)
9 (18%)
3 (6%)

Note. Percent values indicate the percent within the subgroup.
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A6 Simple Comparisons for Physical Functioning Differences According to GI Group and Sex Interaction
MANOVA
main effect

Latent classification GI group
Sex
Male
N
Mean (SD)
Female
N
Mean (SD)

Normal

Mild

Moderate

332
86.62
(.66)

59
77.8
(1.57)

8
55.85
(4.26)

316
83.78
(.68)

199
78.22
(.85)

42
71.4
(1.86)

Post hoc tests
mean difference significance

F

p

η2

Normal
(v)
Mild

Normal
(v)
Moderate

Mild
(v)
Moderate

36.837

< 0.001

.072

***

***

***

27.026

< 0.001

.054

***

***

**

Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant difference.
The mean difference was significant at the .05 level.
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001.
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